| 000 | 01182 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250517091650.0 | ||
| 264 | 0 | _c20160930 | |
| 008 | 201609s 0 0 eng d | ||
| 022 | _a0040-5957 | ||
| 024 | 7 |
_a10.1016/j.therap.2016.02.005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBondon-Guitton, Emmanuelle | |
| 245 | 0 | 0 |
_aThe contribution of pharmacogenetics to pharmacovigilance. _h[electronic resource] |
| 260 |
_bTherapie _cApr 2016 |
||
| 300 |
_a223-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xgenetics |
| 650 | 0 | 4 |
_aDideoxynucleosides _xadverse effects |
| 650 | 0 | 4 |
_aDrug Hypersensitivity _xgenetics |
| 650 | 0 | 4 |
_aDrug Overdose _xepidemiology |
| 650 | 0 | 4 |
_aDrug-Related Side Effects and Adverse Reactions _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPharmacogenetics _xmethods |
| 650 | 0 | 4 | _aPharmacovigilance |
| 700 | 1 | _aDespas, Fabien | |
| 700 | 1 | _aBecquemont, Laurent | |
| 773 | 0 |
_tTherapie _gvol. 71 _gno. 2 _gp. 223-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.therap.2016.02.005 _zAvailable from publisher's website |
| 999 |
_c25927851 _d25927851 |
||